Market Place
Sourcing Support
Company Tracker: Pfizer turns to acquisitions as Covid products’ sales nosedive
Over the last five years, a
lot has changed for Pfizer Inc, one of the world’s leading pharma
DMF submissions rise 12.1% in 2022; India sees 10.6% drop in Type II filings
In 2022, the world finally began to emerge out of Covid-related
restrictions. Though 2020 and 2021
DMF submissions in 2021: India, China continue to top filings
The year
2021 was eclipsed by the Covid-19 pandemic. In our update for the first half of 2020, we h
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
FDA’s 2016 Approvals of New Drugs, Formulations, Strengths & More
After 2 years of sky-high approval numbers, the US Food and Drug Administration’s (FDA) Center
US DMF filings indicate a robust API industry, with multiple first-to-file challenges
This week, PharmaCompass brings you a compilation of the Drug Master Files (DMFs) updates at
Generic challenges, the next first-to-files, GDUFA dues (FY 2016) and more
PharmaCompass has assessed the second quarter US Drug Master
File (DMFs) filings. In our view, with
Who has the biggest one? Sales of the top pharma products by revenue.
We always knew math was fuzzy, but never imagined addition could get so
complicated.
A recent
